Hormonal patterns in men with prediabetes and diabetes in NHANES III: possible links with prostate cancer
- 21 January 2022
- journal article
- research article
- Published by Springer Nature in Cancer Causes & Control
- Vol. 33 (3) , 429-440
Abstract
Purpose Pathways involving sex hormones and insulin-like growth factors (IGFs) have been proposed to explain, in part, the lower risk of prostate cancer among men with diabetes. To gain insights into potential biological mechanisms we explored differences in serum concentrations of sex hormones and IGFs across the trajectory from normoglycemia to prediabetes to poorly controlled diabetes. Methods Using cross-sectional data from the National Health and Nutrition Examination Survey III we examined differences in levels of circulating sex hormones, sex hormone-binding globulin (SHBG), IGF-1, and IFG-binding protein 3 (IGFBP-3), according to diabetes status: no diabetes [n = 648], prediabetes [n = 578], undiagnosed diabetes [n = 106], well-controlled diabetes [n = 42], and poorly controlled diabetes [n = 56]. Adjusted geometric mean concentrations were derived using multivariable linear regression, adjusted for age, race, and other lifestyle factors. Results Total testosterone concentrations were lower among prediabetics (4.89 ng/mL, 95% confidence interval (CI) 4.95–5.21) than men without prediabetes/diabetes (5.29 ng/mL, 95% CI 5.06–5.53) but did not reduce further across diabetes groups. Concentrations of estradiol, estimated free testosterone, SHGB, IGF-1, and IGFBP-3 did not differ. While the ratio of IGF-1 to IGFBP-3 was lower among men with prediabetics and undiagnosed diabetes than men without prediabetes/diabetes, there was no trend across groups. A positive trend for the ratio of estradiol-to-testosterone levels was observed across groups (p trend = 0.045). Conclusion Our findings do not provide clear support for either an androgen driven or IGF-driven pathway for the inverse association between diabetes and prostate cancer risk.Keywords
Funding Information
- National Health and Medical Research Council (1124210)
- National Cancer Institute (P30 CA006973)
This publication has 42 references indexed in Scilit:
- Metabolic Actions of Insulin-Like Growth Factor-I in Normal Physiology and DiabetesEndocrinology and Metabolism Clinics of North America, 2012
- Association Between Serum IGF-1 and Diabetes Among U.S. AdultsDiabetes Care, 2010
- Diabetes and CancerDiabetes Care, 2010
- Association of Diabetes With Prostate Cancer Risk in the Multiethnic CohortAmerican Journal of Epidemiology, 2009
- Diabetes mellitus and risk of prostate cancer in the health professionals follow‐up studyInternational Journal of Cancer, 2008
- Diabetes mellitus and prostate cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening TrialCancer Causes & Control, 2008
- Hormonal profile of diabetic men and the potential link to prostate cancerCancer Causes & Control, 2008
- Sex Differences of Endogenous Sex Hormones and Risk of Type 2 DiabetesJAMA, 2006
- History of Diabetes, Clinical Features of Prostate Cancer, and Prostate Cancer Recurrence-Data from CaPSURETM (United States)Cancer Causes & Control, 2005
- Plasma insulin-like growth factor-1 and binding protein-3 and subsequent risk of prostate cancer in the PSA eraCancer Causes & Control, 2005